EBITDA Margin ratio Analysis of Kazia Therapeutics Ltd ADR - Deep Dive
WARN : Please note that some of the values may not be in base currency

Latest FY EBITDA Margin
Period Ending - Jun-23

-4350825.59


Very Poor EBITDA Margin
Period Ending - Jun-22
-100055204.00

Very Poor EBITDA Margin
Growth
95.65 %
Trailing Twelve Months EBITDA Margin
Period Ending - Jun-23

-3123711.59


Very Poor EBITDA Margin
Most recent Quarter EBITDA Margin
Period Ending - Dec-23

-158973960.00


Very Poor EBITDA Margin
EBITDA Margin Analysis of Kazia Therapeutics Ltd ADR
Ebitda Margin Ratio of Kazia Therapeutics Ltd ADR with value of -3123711.59 means that its operating expenses are Higher in relation to total revenue in trailing twelve months.
Ebitda Margin Ratio of Kazia Therapeutics Ltd ADR with value of -158973960.00 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Dec-23.
EBITDA Margin Ratio of KZIA rose handsomely by 95.65 % this year.
EBITDA Margin Ratio with value of -16.75 was highest in Year Jun-21 in last Five Years.
EBITDA Margin Ratio with value of -100055204.00 was lowest in Year Jun-22 in last Five Years.
Latest EBITDA Margin Ratio with value of -4350825.59 is Greater than Average EBITDA Margin of -21222599.05 in last five years.
Ebitda Margin of Kazia Therapeutics Ltd ADR is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months
Other EBITDA Margin Related Info of KZIA that may interest you.
Kazia Therapeutics Ltd ADR Overview
CodePricePrevious PricePrice ChangeSector
KZIA0.260.2497 4.12 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization.   more ..
EBITDA Margin Formula

EBITDA Margin Related Ratios
NetProfitMarginReturnOnEquity

Tsr Profitability Index
Poor Profitability Stock
FY - Historical EBITDA Margin of Kazia Therapeutics Ltd ADR
PeriodJun-23Jun-22Jun-21Jun-20Jun-19Jun-18Jun-17
EBITDA Margin-4350825.59-100055204.00-16.75-1100942.51-606006.39-36595.97-98.81
Change95.65 %-597380223.37 %100.00 %-81.67 %-1555.94 %-36935.25 %96.49 %
You are view first 7 Records. Log in to view all 25 in Premium view
FY Chart of EBITDA Margin of Kazia Therapeutics Ltd ADR


Note : All Data Generated at the End of Trading Hours (EOD Data)